The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways: Implications in Diabetes Mellitus–Associated Obesity and Vascular Dysfunction
Abstract
We reported aldosterone as a novel adipocyte-derived factor that regulates vascular function. We aimed to investigate molecular mechanisms, signaling pathways, and functional significance of adipocyte-derived aldosterone and to test whether adipocyte-derived aldosterone is increased in diabetes mellitus–associated obesity, which contributes to vascular dysfunction. Studies were performed in the 3T3-L1 adipocyte cell line and mature adipocytes isolated from human and mouse (C57BL/6J) adipose tissue. Mesenteric arteries with and without perivascular fat and mature adipocytes were obtained from obese diabetic db/db and control db/+ mice. Aldosterone synthase (CYP11B2; mRNA and protein) was detected in 3T3-L1 and mature adipocytes, which secrete aldosterone basally and in response to angiotensin II (Ang II). In 3T3-L1 adipocytes, Ang II stimulation increased aldosterone secretion and CYP11B2 expression. Ang II effects were blunted by an Ang II type 1 receptor antagonist (candesartan) and inhibitors of calcineurin (cyclosporine A and FK506) and nuclear factor of activated T-cells (VIVIT). FAD286 (aldosterone synthase inhibitor) blunted adipocyte differentiation. In candesartan-treated db/db mice (1 mg/kg per day, 4 weeks) increased plasma aldosterone, CYP11B2 expression, and aldosterone secretion were reduced. Acetylcholine-induced relaxation in db/db mesenteric arteries containing perivascular fat was improved by eplerenone (mineralocorticoid receptor antagonist) without effect in db/+ mice. Adipocytes possess aldosterone synthase and produce aldosterone in an Ang II/Ang II type 1 receptor/calcineurin/nuclear factor of activated T-cells–dependent manner. Functionally adipocyte-derived aldosterone regulates adipocyte differentiation and vascular function in an autocrine and paracrine manner, respectively. These novel findings identify adipocytes as a putative link between aldosterone and vascular dysfunction in diabetes mellitus–associated obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, the increased aldosterone production by adipocytes in obesity was shown to contribute to the vascular changes associated with this condition (54).”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
In the citing paper
“For instance, adipocyte-derived aldosterone has emerged as a new paradigm in linking obesity with vascular disease (54).”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
In the citing paper
“Moreover, this study revealed that adipocyte-derived aldosterone regulates vascular function in a paracrine manner.”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
In the citing paper
“Adipocytes were found to possess the components necessary for aldosterone synthesis.”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
Citations
Cites
Greenstein, A. S., Khavandi, K., Withers, S., Sonoyama, K., Clancy, O., Jeziorska, M., Laing, I., Yates, A. P., Pemberton, P. W., Malik, R. A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.821181 · Cited by 616
Interaction of calcineurin with substrates and targeting proteins
Li, H., Rao, A., & Hogan, P. G. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.09.011 · Cited by 381
Guo, C., Ricchiuti, V., Lian, B. Q., Yao, T. M., Coutinho, P., Romero, J. R., Li, J., Williams, G. H., & Adler, G. K. (2008) · Circulation · doi:10.1161/circulationaha.107.748640 · Cited by 342
Pivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis
Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., & Zennaro, M.-C. (2007) · The FASEB Journal · doi:10.1096/fj.06-7970com · Cited by 337
The secretory function of adipocytes in the physiology of white adipose tissue
Wang, P., Mariman, E., Renes, J., & Keijer, J. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21386 · Cited by 318
Enhanced Aldosterone Signaling in the Early Nephropathy of Rats with Metabolic Syndrome
Nagase, M., Yoshida, S., Shibata, S., Nagase, T., Gotoda, T., Ando, K., & Fujita, T. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080944 · Cited by 247
Hirata, A., Maeda, N., Hiuge, A., Hibuse, T., Fujita, K., Okada, T., Kihara, S., Funahashi, T., & Shimomura, I. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp191 · Cited by 241
Adipogenic and lipolytic effects of chronic glucocorticoid exposure
Campbell, J. E., Peckett, A. J., D'souza, A. M., Hawke, T. J., & Riddell, M. C. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00045.2010 · Cited by 228
Body Mass Index Predicts Aldosterone Production in Normotensive Adults on a High-Salt Diet
Bentley–Lewis, R., Adler, G. K., Perlstein, T. S., Seely, E. W., Hopkins, P. N., Williams, G. H., & Garg, R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1088 · Cited by 213
Ketonen, J., Jin, S., Martonen, E., & Mervaala, E. M. A. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0661 · Cited by 209
Cited by
Sorted by citations
Items 201–300 of 373
Obesity-Related Glomerulosclerosis—How Adiposity Damages the Kidneys
Zbrzeźniak, J., Winiarska, A., Perkowska‐Ptasińska, A., & Stompór, T. P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136247 · Cited by 20
Beck, L., Su, J., Comerma-Steffensen, S., Pinilla, E., Carlsson, R., Hernanz, R., Sheykhzade, M., Danielsen, C. C., & Simonsen, U. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00667 · Cited by 16
Do obesity and visceral adiposity promote heart failure with reduced ejection fraction?
Packer, M. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf645 · Cited by 21
Rossing, P. R., Anker, S. D., Filippatos, G. S., Pitt, B., Ruilope, L. M., Billings, L. K., Green, J. B., Koya, D., Mosenzon, O., Pantalone, K. M., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15197 · Cited by 15
Cruz‐López, E. O., Uijl, E., & Danser, A. H. J. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001027 · Cited by 16
Fu, X., Almengló, C., Fernández, Á. L., Martínez‐Comendador, J. M., Iglesias-Álvarez, D., Durán‐Muñoz, D., García‐Caballero, T., González‐Juanatey, J. R., Rodríguez‐Mañero, M., & Eiras-Penas, S. (2022) · Cells · doi:10.3390/cells11081264 · Cited by 15
Dudenbostel, T., Li, P., & Calhoun, D. A. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa208 · Cited by 14
Regulation and Functions of the Renin‐Angiotensin System in White and Brown Adipose Tissue
Pahlavani, M., Kalupahana, N. S., Ramalingam, L., & Moustaïd‐Moussa, N. (2017) · Comprehensive physiology · doi:10.1002/j.2040-4603.2017.tb00776.x · Cited by 14
Jemtel, T. H. L., Richardson, W., Samson, R., Jaiswal, A., & Oparil, S. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0713-6 · Cited by 14
Obesity induced hypertension: The main pathophysiological mechanisms
Chumakova, G. A., Kuznetsova, Т. Y., Druzhilov, М. A., & Veselovskaya, N. G. (2021) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2021-27-3-260-268 · Cited by 15
Calcineurin regulates aldosterone production via dephosphorylation of NFATC4
Berber, M., Leng, S., Wengi, A., Winter, D. V., Odermatt, A., Beuschlein, F., Loffing, J., Breault, D. T., & Pentón, D. (2023) · JCI Insight · doi:10.1172/jci.insight.157027 · Cited by 14
Aldosterone and the kidney: a rapidly moving frontier (an update)
Ritz, E., & Tomaschitz, A. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft035 · Cited by 14
Xu, J. R., Qu, P., Du, X., Xiang, Q., Guo, L., Zhu, L., Tan, Y., Fu, Y. H. H., Wen, T., & Liu, L. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.685385 · Cited by 14
What Is the Role of the Adipocyte Mineralocorticoid Receptor in the Metabolic Syndrome?
Gómez-Sánchez, C. E. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05148 · Cited by 14
Mineralocorticoid receptor throughout the vessel: a key to vascular dysfunction in obesity
Pojoga, L. H., Baudrand, R. F., & Adler, G. K. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht158 · Cited by 14
Lakhani, H. V., Zehra, M., Pillai, S. S., Puri, N., Shapiro, J., Abraham, N. G., & Sodhi, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133205 · Cited by 13
RetractedHypertension and human immunodeficiency virus: A paradigm for epithelial sodium channels?
Mutengo, K. H., Masenga, S. K., Mwesigwa, N., Patel, K. P., & Kirabo, A. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.968184 · Cited by 14
Harada, E., Mizuno, Y., Katoh, D., Kashiwagi, Y., Morita, S., Nakayama, Y., Yoshimura, M., Masuzaki, H., Saito, Y., & Yasue, H. (2012) · Clinical Endocrinology · doi:10.1111/cen.12083 · Cited by 13
Cataldi, M., Geronimo, O. D., Trio, R., Scotti, A., Memoli, A., Capone, D., & Guida, B. (2016) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-016-0055-z · Cited by 13
Karashima, S., Yoneda, T., Kometani, M., Ohe, M., Mori, S., Sawamura, T., Furukawa, K., Yamagishi, M., & Takeda, Y. (2016) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2016.1151526 · Cited by 15
Rodríguez-Lara, S. Q., García‐Benavides, L., & Miranda‐Díaz, A. G. (2018) · International Journal of Endocrinology · doi:10.1155/2018/3614303 · Cited by 12
Vaidya, A., UNDERWOOD, P. C., Annes, J. P., Sun, B., Williams, G. H., Forman, J. P., & Williams, J. S. (2012) · Metabolism · doi:10.1016/j.metabol.2012.10.001 · Cited by 11
Bender, S. B., Jia, G., & Sowers, J. R. (2014) · Diabetes · doi:10.2337/db14-1425 · Cited by 12
Incretin-Based Therapies: A Paradigm Shift in Blood Pressure Management?
Dreher, L., Kylies, D., Danser, A. H. J., & Wenzel, U. O. (2025) · Hypertension · doi:10.1161/hypertensionaha.125.25112 · Cited by 11
Liu, P., Feng, J., Kong, F., Lu, Q., Xu, H., Meng, J., & Jiang, Y. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.09.017 · Cited by 11
Xu, C. (2023) · Endocrine · doi:10.1007/s12020-023-03566-6 · Cited by 11
Lee, M., Kwon, D. Y., & Park, J. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.232 · Cited by 11
Assersen, K. B., Jensen, P. S., Briones, A. M., Rasmussen, L. M., Marcussen, N., Toft, A., Vanhoutte, P. M., Jensen, B. L., & Hansen, P. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00391.2018 · Cited by 11
Self-citationSchuh, K., Häussler, S., Sadri, H., Prehn, C. P., Lintelmann, J., Adamski, J., Koch, C., Frieten, D., Ghaffari, M. H., Dusel, G., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-06014-z · Cited by 11
Hundemer, G. L., Agharazii, M., Madore, F., Piché, M., Gagnon, C., Bussières, A., St‐Jean, M., Leung, A. A. C., Kline, G. A., Sood, M. M., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae566 · Cited by 9
Self-citationCalcineurin inhibitors and the renin–angiotensin–aldosterone system
Berber, M., & Pentón, D. (2024) · Acta Physiologica · doi:10.1111/apha.14248 · Cited by 10
Radakrishnan, A., Agrawal, S., Singh, N., Barbieri, A., Shaw, L. J., Gulati, M., & Lala, A. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.100928 · Cited by 12
Interfering with mineralocorticoid receptor activation: the past, present, and future
Dorrance, A. M. (2014) · F1000Prime Reports · doi:10.12703/p6-61 · Cited by 10
Berillo, O., Coelho, S. C., Mahjoub, N., Offermanns, S., Paradis, P., & Schiffrin, E. L. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002880 · Cited by 10
Gut microbiota and hypertension
Kotrova, A., Shishkin, A. N., Ермоленко, Е. И., Александровна, С. Д., & Воловникова, В. А. (2021) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2020-26-6-620-628 · Cited by 10
Romantsova, T. I., & Ovsyannikovna, A. V. (2015) · Obesity and metabolism · doi:10.14341/omet201545-13 · Cited by 10
Extra-adrenal Glucocorticoid and Mineralocorticoid Biosynthesis
Gómez-Sánchez, C. E., & Gómez-Sánchez, E. P. (2022) · Endocrinology · doi:10.1210/endocr/bqac016 · Cited by 10
Mineralocorticoid receptor antagonists for the treatment of hypertension and the metabolic syndrome
Pitt, B. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04117 · Cited by 9
Chronic Kidney Disease in Patients With Heart Failure With a Preserved Ejection Fraction
Packer, M., Testani, J. M., Butler, J., Zannad, F. M., Lam, C. S. P., Vaduganathan, M., Fang, J. C., & Borlaug, B. A. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.08.086 · Cited by 12
Packer, M. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.01.038 · Cited by 9
Protecting the Heart in Obesity: Role of ACE2 and Its Partners
Touyz, R. M. (2015) · Diabetes · doi:10.2337/dbi15-0014 · Cited by 9
Self-citationA Brief Introduction into the Renin-Angiotensin-Aldosterone System: New and Old Techniques
Thatcher, S. E. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7030-8_1 · Cited by 9
Mineralocorticoids and Cardiovascular Disease in Females with Insulin Resistance and Obesity
Nayyar, M., Lastra, G., & Manrique‐Acevedo, C. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0887-6 · Cited by 9
Fujii, H., Watanabe, K., Kono, K., Goto, S., Watanabe, S., & Nishi, S. (2018) · Clinical and Experimental Nephrology · doi:10.1007/s10157-018-1680-1 · Cited by 9
Resistant Hypertension in Diabetes Mellitus
Bayliss, G. P., Weinrauch, L. A., & D’Elia, J. A. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0516-y · Cited by 9
Reviving the use of aldosterone inhibitors in treating hypertension in obesity
Huby, A.-C., & de Chantemèle, E. J. B. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00133.2015 · Cited by 9
The mineralocorticoid receptor: a new player controlling energy homeostasis
Kuhn, E., & Lombès, M. (2013) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0033 · Cited by 10
Kuate, D., Nash, R. J., Bartholomew, B. B., & Penkova, Y. (2015) · Natural Product Communications · doi:10.1177/1934578x1501000737 · Cited by 9
Finerenone According to Insulin Resistance in Heart Failure: Insights from the FINEARTS-HF Trial
Ostrominski, J. W., Claggett, B. L., Desai, A. S., Jhund, P. S., Lam, C. S. P., Senni, M., Shah, S. J., Voors, A. A., Zannad, F. M., Pitt, B., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.70034 · Cited by 8
Lin, C., Lee, H., Chen, C., Wang, C., Sung, F., & Su, T. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01502-z · Cited by 8
Hu, Y., Bao, J., Gao, Z., Ye, L., & Wang, L. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s446904 · Cited by 9
Mineralocorticoid receptor overactivation in diabetes mellitus: role of O-GlcNAc modification
Jo, R., Itoh, H., & Shibata, H. (2024) · Hypertension Research · doi:10.1038/s41440-024-01734-3 · Cited by 9
Challenges in obesity and primary aldosteronism: Diagnosis and treatment
Gershuni, V. M., Herman, D. S., Kelz, R. R., Roses, R. E., Cohen, D. L., Trerotola, S. O., Fraker, D. L., & Wachtel, H. (2019) · Surgery · doi:10.1016/j.surg.2019.03.036 · Cited by 8
Francischetti, E. A., de Abreu, V. G., Figueiredo, L. F. D. S., Dezonne, R. S., & Coutinho, E. S. F. (2020) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-019-00393-x · Cited by 8
Greco, E. A., Feraco, A., Marzolla, V., Mirabelli, M., Cimino, L., Armani, A., Brunetti, A., & Caprio, M. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.07.010 · Cited by 8
Role of platelet factor 4 in arteriovenous fistula maturation failure: What do we know so far?
Xiao, Y., Vázquez-Padrón, R. I., Martinez, L., Singer, H. A., Woltmann, D., & Salman, L. H. (2022) · The Journal of Vascular Access · doi:10.1177/11297298221085458 · Cited by 8
Obesity-Associated Hypertension: the Upcoming Phenotype in African-American Women
Samson, R., Qi, A., Jaiswal, A., Jemtel, T. H. L., & Oparil, S. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0738-x · Cited by 10
Endothelium-dependent hyperpolarization (EDH) in diet-induced obesity
Gotō, K., & Kitazono, T. (2020) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2020.100062 · Cited by 8
Puzantian, H. V., Townsend, R. R., & Bansal, S. (2024) · Journal of Clinical Hypertension · doi:10.1111/jch.14898 · Cited by 7
Advances in the management of obesity and heart failure: latest evidence from clinical trials
Costa, T. A., & Harrington, J. (2025) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001214 · Cited by 7
Mitsuno, R., Kaneko, K., Nakamura, T., Kojima, D., Mizutani, Y., Azegami, T., Yamaguchi, S., Yamada, Y., Jinzaki, M., Kinouchi, K., et al. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad154 · Cited by 7
Zhang, Y., Wu, T., Xie, J., Yan, L., Guo, X., Xu, W., & Wang, L. (2021) · International Urology and Nephrology · doi:10.1007/s11255-020-02759-6 · Cited by 7
Griffin, T. P., Islam, M. N., Blake, L., Bell, M., Griffin, M. D., & O’Shea, P. M. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0794-7026 · Cited by 7
Salman, A., Salman, M. A., Shawkat, M., Hassan, S. A., Saad, E. H. A. I., Hussein, A. M., Mohamed, O. R., Tourky, M. S., Shaaban, H. E., Allah, N. A., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14352 · Cited by 7
Schinzari, F., Stefano, A. D., Sica, G. S., Mettimano, M., Cardillo, C., & Tesauro, M. (2024) · Physiological Reports · doi:10.14814/phy2.70062 · Cited by 6
da Costa, R. M., Bruder‐Nascimento, A., Alves, J. V., Awata, W. M. C., Singh, S., Rodrigues, D., Bruder-Nascimento, T. B., & Tostes, R. C. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00829.2024 · Cited by 6
Evaluating phase II results of Baxdrostat, an aldosterone synthase inhibitor for hypertension
Awosika, A., Cho, Y., Bose, U., Omole, A. E., & Adabanya, U. (2023) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2023.2276755 · Cited by 8
Butt, J. H., Solomon, S. D., Vaduganathan, M., van Veldhuisen, D. J., Køber, L., Pitt, B., Zannad, F. M., Jhund, P. S., & McMurray, J. J. V. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3665 · Cited by 6
Wang, W., Wang, C.-S., Wang, C., Yang, A., & Lin, C. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19126964 · Cited by 6
Adiposity, aldosterone and plasma renin activity among African Americans: The Jackson Heart Study
Lee, G., Kluwe, B., Zhao, S., Kline, D., Nedungadi, D., Brock, G. N., Odei, J. B., Kesireddy, V., Pohlman, N., Sims, M., et al. (2023) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2023.100126 · Cited by 6
Fierabracci, P., Tamberi, A., & Santini, F. (2015) · Springer eBooks · doi:10.1007/978-3-319-15356-8_4 · Cited by 6
Hofmann, A., Brunßen, C., Peitzsch, M., Balyura, M., Mittag, J., Frenzel, A., Jannasch, A., Brown, N., Weldon, S. M., Gueneva-Boucheva, K., et al. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-101821 · Cited by 6
Ватутин, Н. Т., & Shevelok, A. N. (2016) · Clinical Medicine (Russian Journal) · doi:10.18821/0023-2149-2016-94-4-265-269 · Cited by 6
Salt Intake, Aldosterone Secretion, and Obesity: Role in the Pathogenesis of Resistant Hypertension
Bełtowski, J. (2021) · American Journal of Hypertension · doi:10.1093/ajh/hpab015 · Cited by 6
Nedd4-2 ablation in kidney improves glycaemic control in diabetic mice
Manning, J. A., Jesudason, S., Moretti, P. A. B., Pitson, S. M., Chou, A. S. Y., Shabbar, M., Saad, S., Pollock, C. A., & Kumar, S. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07826-3 · Cited by 5
The mineralocorticoid system, cardiometabolic health and its interplay with adipose tissue
Thuzar, M., Halim, M. A., & Stowasser, M. (2024) · Journal of Endocrinology · doi:10.1530/joe-24-0119 · Cited by 6
Bansal, S., Puzantian, H. V., & Townsend, R. R. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-024-09081-2 · Cited by 5
Bavuu, O., Fukuda, D., Ganbaatar, B., Matsuura, T., Ise, T., Kusunose, K., Yamaguchi, K., Yagi, S., Yamada, H., Soeki, T., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175190 · Cited by 5
Hathorn, B., Haykowsky, M. J., Almandoz, J. P., Pandey, A., Sarma, S., Hearon, C. M., Babb, T. G., Balmain, B. N., Fu, Q., Zaha, V. G., et al. (2025) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.03.015 · Cited by 5
A role for tissue plasminogen activator in thrombotic thrombocytopenic purpura
Hoirisch-Clapauch, S., & Nardi, A. E. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.09.032 · Cited by 5
Lee, W. J., Chait, A., & Kim, F. (2012) · Diabetes · doi:10.2337/db12-1036 · Cited by 5
Victorio, J. A., Barssotti, L., Aprahamian, T. R., Costa, R. G., Mousovich‐Neto, F., Oliveira, H. C. F., Mori, M. A., Rossoni, L. V., & Davel, A. P. (2024) · Endocrinology · doi:10.1210/endocr/bqae053 · Cited by 4
Mitsuno, R., Nakamura, T., Nakamura, K., Kaneko, K., Kojima, D., Mizutani, Y., Yamada, Y., Jinzaki, M., Azegami, T., Kanda, T., et al. (2025) · Hypertension Research · doi:10.1038/s41440-025-02401-x · Cited by 4
Maitituersun, A., Heizhati, M., Li, N., Gan, L., Li, M., Yao, L., Yang, W., Liu, S., Aierken, X., Wang, H., et al. (2024) · BMC Public Health · doi:10.1186/s12889-024-18796-0 · Cited by 4
Body mass index predicts aldosterone production in hypertensive postmenopausal women
Li, L., Hou, X., Geng, X., & Xu, Y. (2019) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2019.1649683 · Cited by 4
Nedungadi, D., Adesanya, T. M. A., Rayan, M. N., Zhao, S., Williams, A., Brock, G. N., & Joseph, J. J. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae396 · Cited by 4
Fat tissue and adrenal function: mechanisms of mutual influence
Mazurina, N. V., Ershova, E. V., Troshina, E. A., Семеновна, С. Е., Tyulpakov, A. N., & Иоутси, В. А. (2019) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2019-4-70-77 · Cited by 4
Shevelok, A. N. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-3991 · Cited by 5
Shafeeq, N. K., Hussein, T. A., & Abass, E. A. (2021) · Ibn AL- Haitham Journal For Pure and Applied Science · doi:10.30526/34.3.2675 · Cited by 5
Can EAT be an INOCA goalkeeper
Tong, S., Shuwen, Z., Hengbin, W., & Zeng, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1028429 · Cited by 3
Martins, I. V. O., Dourado, T. M. H., Pimenta, G. F., de Mello, M. M. B., Fedoce, A. G., Awata, W. M. C., de Castro, M. M., Tostes, R. C., & Tirapelli, C. R. (2025) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-025-03094-4 · Cited by 3
Indications for renal denervation: a balanced approach?
Bakris, G. L. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.85 · Cited by 3
Obesity-stimulated aldosterone release is not related to an S1P-dependent mechanism
Werth, S. C., Müller‐Fielitz, H., & Raasch, W. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0550 · Cited by 3
Kluwe, B., Pohlman, N., Kesireddy, V., Zhao, S., Tan, Y., Kline, D., Brock, G. N., Odei, J. B., Effoe, V. S., Echouffo-Tcheugui, J. B., et al. (2023) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2023.100494 · Cited by 3
Assersen, K. B., Jensen, B. L., Enggaard, C., Vanhoutte, P. M., & Hansen, P. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-02909-0 · Cited by 4
Pathophysiology and Optimal Management of Hypertension in Patients with Cardiometabolic Syndrome
Ihm, S. (2021) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2021.1.e3 · Cited by 3
ALDOSTERONE AND OBESITY: WHERE TO LOOK FOR THE KEY TO THERAPY?
Vatutin, N. T., Shevelok, A. N., & Degtiarova, G. E. (2016) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2016-6-4-21-29 · Cited by 3
Obesity Hypertension: Clinical Aspects
Macumber, I. R., & Flynn, J. T. (2023) · Springer eBooks · doi:10.1007/978-3-031-06231-5_17 · Cited by 3
Launonen, H., Toivio, L., Lindén, J., Siltari, A., Salmenkari, H., Korpela, R., & Vapaatalo, H. (2023) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13918 · Cited by 2
Adrenal–adipose tissue crosstalk in health and disease
Jiang, M., Stifel, U., Blüher, M., Lefèbvre, H., Bornstein, S. R., & Bechmann, N. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf252 · Cited by 4
Metadata
- Authors
- Briones, A. M., Nguyen Dinh Cat, A., Callera, G. E., Yogi, A., Burger, D., He, Y., Corrêa, J. W., Gagnon, A. M., Gomez-Sanchez, C. E., Gomez-Sanchez, E. P., Sorisky, A., Ooi, T. C., Ruzicka, M., Burns, K. D., & Touyz, R. M.
- Affiliations
- University of Ottawa (CA)
- From the Kidney Research Centre (A.M.B., A.N.D.C., G.E.C., A.Y., D.B., Y.H., J.W.C., K.D.B., R.M.T.), Chronic Disease Program (A.M.G., A.S., T.C.O.), Ottawa Hospital Research Institute, and Division of Nephrology, Department of Medicine (M.R.), University of Ottawa, Ontario, Canada; G.V. (Sonny) Montgomery Veterans Affairs and Division of Endocrinology, Department of Medicine, University of Mississippi Medical Centers, Jackson, MS (C.E.G.-S., E.P.G.-S.); Current address (A.M.B.): Departamento...
- ORCID
- Venue
- Hypertension
- Published
- 2012-05
- Volume
- 59
- Issue
- 5
- Pages
- 1069-1078
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2111017518
- Cited by
- 375
- References
- 39
- Citations by year
- 2026: 24 · 2025: 29 · 2024: 26 · 2023: 30 · 2022: 18 · 2021: 28 · 2020: 22 · 2019: 19 · 2018: 27 · 2017: 21 · 2016: 27 · 2015: 35 · 2014: 32 · 2013: 27 · 2012: 10
- FWCI
- 26.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- aldosterone synthase, calcineurin, NFAT, angiotensin II, angiotensin II type 1 receptor, adipogenesis, vascular dysfunction, db/db mice, perivascular adipose tissue, mesenteric arteries, acetylcholine-induced relaxation, mineralocorticoid receptor, candesartan, eplerenone, autocrine and paracrine signaling
- MeSH terms
- Aldosterone, Animals, Benzimidazoles, Biphenyl Compounds, Cells, Cultured, Diabetic Angiopathies, Disease Models, Animal, Humans, Mice, Inbred C57BL, Obesity, Random Allocation, Sensitivity and Specificity, Tetrazoles, Signal Transduction, Adipocytes, Calcineurin, Diabetes Complications, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review